Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Gross Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Gross Margin for 3 consecutive years, with 90.0% as the latest value for Q1 2022.

  • Quarterly Gross Margin fell 825.0% to 90.0% in Q1 2022 from the year-ago period, while the trailing twelve-month figure was 90.0% through Dec 2022, down 737.0% year-over-year, with the annual reading at 90.0% for FY2022, 737.0% down from the prior year.
  • Gross Margin for Q1 2022 was 90.0% at SELLAS Life Sciences, down from 94.74% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q4 2020, with the low at 90.0% in Q1 2022.
  • Average Gross Margin over 3 years is 95.75%, with a median of 96.49% recorded in 2021.
  • Peak annual rise in Gross Margin hit -825bps in 2022, while the deepest fall reached -825bps in 2022.
  • Over 3 years, Gross Margin stood at 100.0% in 2020, then fell by -5bps to 94.74% in 2021, then fell by -5bps to 90.0% in 2022.
  • According to Business Quant data, Gross Margin over the past three periods came in at 90.0%, 94.74%, and 98.25% for Q1 2022, Q2 2021, and Q1 2021 respectively.